Literature DB >> 6801201

Interactions of di-n-propylacetate, gabaculine, and aminooxyacetic acid: anticonvulsant activity and the gamma-aminobutyrate system.

J D Wood, E Kurylo, S K Tsui.   

Abstract

Di-n-propylacetate (DPA), aminooxyacetic acid (AOAA), and gabaculine were administered alone or in combination to Swiss mice. Six hours after administration of the drugs the anticonvulsant action (against isonicotinic acid hydrazide-induced seizures) of AOAA and DPA combined was less than that of AOAA alone. The cause of this phenomenon appeared to be an interaction between DPA and AOAA with respect to inhibition of GABA-T activity, resulting in a long-term diminished inhibition by AOAA, which in turn led to a lessening of the AOAA-induced elevation in the GABA content of nerve endings (synaptosomes). An excellent correlation was observed between the delay in onset of seizures and the elevation of synaptosomal GABA content.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6801201     DOI: 10.1111/j.1471-4159.1981.tb06313.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  3 in total

1.  Accumulation of labeled gamma-aminobutyric acid into rat brain and brain synaptosomes after i.p. injection.

Authors:  L Vignolo; A Cupello; P Mainardi; M V Rapallino; A Patrone; C Loeb
Journal:  Neurochem Res       Date:  1992-02       Impact factor: 3.996

2.  Evaluation of the mechanisms by which gamma-amino-butyric acid in association with phosphatidylserine exerts an antiepileptic effect in the rat.

Authors:  E Benassi; G Besio; A Cupello; P Mainardi; A Patrone; M V Rapallino; L Vignolo; C W Loeb
Journal:  Neurochem Res       Date:  1992-12       Impact factor: 3.996

3.  Studies on the role of serotonin in different regions of the rat central nervous system on pentylenetetrazol-induced seizures and the effect of di-n-propylacetate.

Authors:  M Lazarova; C Bendotti; R Samanin
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1983-03       Impact factor: 3.000

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.